4-[2-(6-nitro-1h-benzimidazol-2-yl)ethyl]morpholine (CHEM283930)
| Record Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||
| Creation Date | 2026-08-28 00:46:44 UTC | ||||||||
| Update Date | 2026-08-28 00:46:44 UTC | ||||||||
| Accession Number | CHEM283930 | ||||||||
| Identification | |||||||||
| Common Name | 4-[2-(6-nitro-1h-benzimidazol-2-yl)ethyl]morpholine | ||||||||
| Class | Small Molecule | ||||||||
| Description | 4-[2-(6-nitro-1h-benzimidazol-2-yl)ethyl]morpholine belongs to the benzimidazoles, a class of organoheterocyclic compounds within the organic compounds. It has the chemical formula C13H16N4O3 and an average molecular weight of 276.29 g/mol. | ||||||||
| Contaminant Sources | Not Available | ||||||||
| Contaminant Type | Not Available | ||||||||
| Chemical Structure |  | ||||||||
| Synonyms | Not Available | ||||||||
| Chemical Formula | C13H16N4O3 | ||||||||
| Average Molecular Mass | Not Available | ||||||||
| Monoisotopic Mass | 276.122 g/mol | ||||||||
| CAS Registry Number | 16671-68-4 | ||||||||
| IUPAC Name | 4-[2-(6-nitro-1h-benzimidazol-2-yl)ethyl]morpholine | ||||||||
| Traditional Name | Not Available | ||||||||
| SMILES | C1COCCN1CCC2=NC3=C(N2)C=C(C=C3)[N+](=O)[O-] | ||||||||
| InChI Identifier | InChI=1S/C13H16N4O3/c18-17(19)10-1-2-11-12(9-10)15-13(14-11)3-4-16-5-7-20-8-6-16/h1-2,9H,3-8H2,(H,14,15) | ||||||||
| InChI Key | LQUNJTQVGSEEBJ-UHFFFAOYSA-N | ||||||||
| Chemical Taxonomy | |||||||||
| Classification | Not classified | ||||||||
| Biological Properties | |||||||||
| Status | Detected and Not Quantified | ||||||||
| Origin | Not Available | ||||||||
| Cellular Locations | Not Available | ||||||||
| Biofluid Locations | Not Available | ||||||||
| Tissue Locations | Not Available | ||||||||
| Pathways | Not Available | ||||||||
| Applications | Not Available | ||||||||
| Biological Roles | Not Available | ||||||||
| Chemical Roles | Not Available | ||||||||
| Physical Properties | |||||||||
| State | Not Available | ||||||||
| Appearance | Not Available | ||||||||
| Experimental Properties |
| ||||||||
| Predicted Properties | Not Available | ||||||||
| Spectra | |||||||||
| Spectra |
| ||||||||
| Toxicity Profile | |||||||||
| Route of Exposure | Not Available | ||||||||
| Mechanism of Toxicity | Not Available | ||||||||
| Metabolism | Not Available | ||||||||
| Toxicity Values | Not Available | ||||||||
| Lethal Dose | Not Available | ||||||||
| Carcinogenicity (IARC Classification) | Not Available | ||||||||
| Uses/Sources | Not Available | ||||||||
| Minimum Risk Level | Not Available | ||||||||
| Health Effects | Not Available | ||||||||
| Symptoms | Not Available | ||||||||
| Treatment | Not Available | ||||||||
| Concentrations | |||||||||
| Not Available | |||||||||
| External Links | |||||||||
| Identifiers | Not Available | ||||||||
| References | |||||||||
| Synthesis Reference | Not Available | ||||||||
| MSDS | Not Available | ||||||||
| General References | Not Available | ||||||||
